Marsh & McLennan (MRSH) Downgraded by Mizuho Following Insurance Sector Selloff
On February 27, Mizuho analyst Yaron Kinar downgraded Marsh & McLennan Companies, Inc. (NYSE:MRSH) to Neutral from Outperform. The analyst also lowered the price target to $199 from $213.



